Crossmark

IGFBP in tumor immunity: a novel target for cancer immunotherapy

Crossref DOI link: https://doi.org/10.1186/s12967-026-08204-z

Published Online: 2026-05-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Lei, Qingqiang

Lin, Liangbin

Yu, Hui https://orcid.org/0000-0002-0211-9377
License Information

Text and Data Mining valid from 2026-05-07

Version of Record valid from 2026-07-01
More Information

Article History

Received: 4 December 2025

Accepted: 23 April 2026

First Online: 7 May 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors declare no potential conflict of interest.